Despite the frequency with which it occurs, familial hypercholesterolemia often goes undiagnosed, with only 10% of affected patients aware of this genetic disorder.
Researchers evaluated the prevalence of elevated triglyceride levels in adults with and without statin use and the related 10-year predicted risk for atherosclerotic cardiovascular disease.
Compared with men, women who have diabetes experience greater changes in the cumulative burden of cardiovascular risk factors from young to middle-age adulthood.
Researchers examined whether lipoprotein(a) cholesterol life-years can effectively measure cumulative risk for atherosclerotic cardiovascular disease and questioned whether this metric may apply to the incidence of aortic valve calcification.
Investigators sought to determine the effect HDL-C subparticles HDL2-C and HDL3-C have on assessing CAD severity in patients who receive statin therapy.
Investigators evaluated the effect of linagliptin vs placebo on cardiovascular and kidney disease outcomes in patients with T2D at high risk for cardiovascular and renal events.
Amgen announced that all Repatha (evolocumab) devices are now available at a 60% reduced list price. This includes the pre-filled syringe, the SureClick autoinjector, and the Pushtronex device, an on-body infusor with prefilled cartridge.
